Brolucizumab sold under trade name Beovu among others, is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD)... Wikipedia

Manufacturer's Website: Beovu                                                                                                                          Average retail cost: *

*This drug is administered by your healthcare practitioner, which usually means it may be expensive.

Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that is approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion... Wikipedia

Manufacturer's Website: Byooviz                                                                                                                       Average retail cost: *

* This drug is only available at select specialty pharmacies, which usually means it may be expensive.

Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that is approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion... Wikipedia

Manufacturer's Website: Cimerli                                                                                                                       Average retail cost: *

*This drug is administered by your healthcare practitioner, which usually means it may be expensive.

Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer... Wikipedia

Manufacturer's Website: Eylea                                                                                                                       Average retail cost: *

* This drug is only available at select specialty pharmacies, which usually means it may be expensive.

Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that is approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion... Wikipedia

Manufacturer's Website: Lucentis                                                                                                                           Average retail cost: *

* This drug is only available at select specialty pharmacies, which usually means it may be expensive.

Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that is approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion... Wikipedia

Manufacturer's Website: Susvimo                                                                                                                    Average retail cost: *

*This drug is administered by your healthcare practitioner, which usually means it may be expensive.

Faricimab is indicated for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)... Wikipedia

Manufacturer's Website: Vabysmo                                                                                                                          Average retail cost: *

*This drug is administered by your healthcare practitioner, which usually means it may be expensive.